AlphaCentric Advisors LLC

Position in INSM — INSMED Inc

CIK 1913464 SAN JUAN, PR

Position in INSM

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$1,451,076

+$130,461 QoQ

Shares Held

8,874

+16.9% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

1.78%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

15 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AlphaCentric Advisors LLC holds $25,792,014 across 49 Biotechnology names. INSM ranks #3 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,931	$2,201,888
2	IONS	Ionis Pharmaceuticals Inc	19,587	$1,470,787
3	INSM	INSMED Inc This page	8,874	$1,451,076
4	INCY	Incyte Corp	14,245	$1,340,739
5	ROIV	Roivant Sciences Ltd.	47,667	$1,320,375
6	ARGX	Argenx SE	1,794	$1,310,068
7	AXSM	Axsome Therapeutics, Inc.	6,438	$1,088,150
8	ASND	Ascendis Pharma A/S	4,526	$1,035,231

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,451,076	8,874	+16.9%	Shares	Other	2026-05-07
2025-12-31	$1,320,615	7,588	+93.1%	Shares	Other	2026-02-12
2024-12-31	$271,327	3,930	-21.4%	Shares	Other	2025-01-31
2024-09-30	$365,000	5,000	-93.8%	Shares	Other	2024-10-30
2023-09-30	$2,020,000	80,000	-15.8%	Shares	Other	2023-11-13
2023-06-30	$2,004,500	95,000	+12.4%	Shares	Other	2023-08-08
2023-03-31	$1,440,725	84,500	+322.5%	Shares	Other	2023-05-12
2022-12-31	$399,600	20,000	-29.8%	Shares	Other	2023-02-13
2021-12-31	$776,340	28,500	0.0%	Shares	Other	2022-02-25
2021-09-30	$784,890	28,500	+18.8%	Shares	Other	2022-03-09
2021-06-30	$683,040	24,000	+2081.8%	Shares	Other	2022-03-09
2021-03-31	$37,466	1,100	0.0%	Shares	Other	2022-03-09
2020-12-31	$36,619	1,100	+68.5%	Shares	Other	2022-03-11
2020-09-30	$20,987	653	+117.7%	Shares	Other	2022-03-11
2020-06-30	$8,262	300	—	Shares	Other	2022-03-11
No filing history on record for this holder in this stock.